Our

Tolerance Induction

is an alternative to the wrecking ball approach of immunosuppressants. Flexible delivery routes based on patient needs.

 

LAPIX-TI Pipelines

TI updates pipline.PNG

Tolerance Induction

Why We’re Different.

 
 
autoimmune.png
 

Auto-Immune

• Current approaches to treat autoimmune diseases depend on non-specifically eliminating/disrupting the immune response at the complement, cellular or humoral level.

• LAPIX-TI re-educates the immune system to shift the T cell imbalance from auto-reactive to tolerogenic T-reg, thus addressing the underlying pathology.

 
 
ERT.png
 

Enzyme Replacement Therapy (ERT)/ Gene Therapy

• No FDA-approved approach exists to address the immunogenicity of ERT/Gene therapy.

• Clinical management of the issue is institution-dependent and relies on extensive use of immune-suppressive agents.

• By targeting the TIM pathway, LAPIX-TI is a more natural method of antigen-specific tolerance induction compared to other commercial experimental approaches in early research and development.

• LAPIX-TI therapies can be administered orally or subcutaneously offer great flexibility to patients and partners